Monday, May 10, 2021 8:12:49 AM
Summary
Buyout Target Potential (Bristol Myers-IMF Therapeutics $2.3B)
N2RF6 10X Less Toxic-Most Advanced in industry
VariousCancers, Lupus, Rare Blood & Auto Immune Disease Treatments
Bio Tech-Stem Cell Clinical Stage Company
https://seekingalpha.com/instablog/32618395-small-cap-solutions-llc/5024702-is-regen-biopharma-buyout-target-potential-otcqb-rgbp
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM